These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31261222)

  • 1. Successful Use of Dupilumab for Recalcitrant Atopic Dermatitis in an HIV Patient.
    Marks DH; Piantadosi AL; Patil SU; Raff A; Yu J
    Dermatitis; 2019; 30(4):276-277. PubMed ID: 31261222
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Doolan BJ; Yeon J; Baker DA; Whitfeld MJ
    AIDS Res Hum Retroviruses; 2022 Feb; 38(2):76-79. PubMed ID: 34384267
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of dupilumab in a patient with severe atopic dermatitis and HIV infection, with 15 months of follow-up.
    Romagnuolo M; Angileri L; Tavecchio S; Marzano AV; Ferrucci S
    Clin Exp Dermatol; 2020 Aug; 45(6):762-763. PubMed ID: 32379943
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of dupilumab in a patient with atopic dermatitis, severe asthma, and HIV infection.
    Brodska P; Panzner P; Sedlacek D; Terl M; Cetkovska P
    Dermatol Ther; 2020 Nov; 33(6):e14159. PubMed ID: 32776586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report.
    Uchida H; Kamata M; Watanabe A; Agematsu A; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    Acta Derm Venereol; 2019 Jun; 99(7):675-676. PubMed ID: 30938821
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of dupilumab in patients who are HIV-positive: report of four cases.
    Mollanazar NK; Qiu CC; Aldrich JL; Tedaldi E; Valdes-Rodriguez R; Savage KT; Hsu S
    Br J Dermatol; 2019 Dec; 181(6):1311-1312. PubMed ID: 31206599
    [No Abstract]   [Full Text] [Related]  

  • 7. Safe and effective treatment of atopic dermatitis using dupilumab over 23 months in a patient with HIV.
    Lor M; Villa N; Holland V
    Dermatol Ther; 2020 Nov; 33(6):e14271. PubMed ID: 32882092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dupilumab for treatment of atopic dermatitis in patients living with HIV: a case series.
    Nusbaum KB; Kaffenberger BH; Paradiso Bs MM; Sopkovich JA; Daou H; Seminario-Vidal L; Trinidad JC
    Int J Dermatol; 2021 Sep; 60(9):e344-e346. PubMed ID: 33661522
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful preoperative intervention of dupilumab in high-risk surgery in a patient with severe atopic dermatitis.
    Goto H; Moriki M; Sano Y; Yagi H; Tokura Y
    J Dermatol; 2020 Feb; 47(2):e50-e51. PubMed ID: 31823419
    [No Abstract]   [Full Text] [Related]  

  • 10. Restoration of sweating disturbance in atopic dermatitis treated with dupilumab.
    Mizukawa Y; Sato Y; Ohyama M; Shiohara T
    J Dermatol Sci; 2020 Oct; 100(1):79-81. PubMed ID: 32900571
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective treatment of atopic dermatitis with dupilumab in an HIV-positive patient.
    Olbricht N; Kromer C; Forkel S; Schön MP; Buhl T
    J Dtsch Dermatol Ges; 2020 Dec; 18(12):1488-1490. PubMed ID: 32909372
    [No Abstract]   [Full Text] [Related]  

  • 12. Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis.
    McKenzie PL; Castelo-Soccio L
    J Am Acad Dermatol; 2021 Jun; 84(6):1691-1694. PubMed ID: 33484763
    [No Abstract]   [Full Text] [Related]  

  • 13. Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.
    Magdaleno-Tapial J; Valenzuela-Oñate C; García-Legaz-Martínez M; Martínez-Domenech Á; Pérez-Ferriols A
    Australas J Dermatol; 2020 May; 61(2):e223-e225. PubMed ID: 31766073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series.
    Armario-Hita JC; Pereyra-Rodriguez J; Silvestre JF; Ruiz-Villaverde R; Valero A; Izu-Belloso R; Jáuregui-Presa I; Curto-Barredo L; Figueras-Nart I; Herranz-Pinto P; Herraez-Herrera L; Ortiz-de-Frutos FJ; Martinez-Pilar L; Sastre J; Serra-Baldrich E
    Br J Dermatol; 2019 Nov; 181(5):1072-1074. PubMed ID: 31021399
    [No Abstract]   [Full Text] [Related]  

  • 15. Young HIV-positive male patient with severe atopic dermatitis on dupilumab and SARS-CoV-2 infection, a pioneer hypothesis.
    Ordóñez-Rubiano MF; Rubiano-Mojica PC; Casas M
    Int J Dermatol; 2021 Apr; 60(4):514-515. PubMed ID: 33644864
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of recurrent exit site and tunnel infections caused by atopic dermatitis with dupilumab: A case report.
    Noda R; Ishibashi Y
    Ther Apher Dial; 2022 Feb; 26(1):255-256. PubMed ID: 34018694
    [No Abstract]   [Full Text] [Related]  

  • 17. Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series.
    Ruiz-Villaverde R; Dominguez-Cruz J; Armario-Hita JC; Martinez-Pilar L; Alcantara-Luna S; Pereyra-Rodriguez JJ
    Dermatol Ther; 2019 Jul; 32(4):e12931. PubMed ID: 30980485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Median canaliform nail dystrophy of Heller in a patient with atopic dermatitis: 'miraculous' healing with dupilumab.
    Giura MT; Viola R; Dika E; Ribero S; Ortoncelli M
    Clin Exp Dermatol; 2020 Jul; 45(5):601-602. PubMed ID: 31889326
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
    Zimmermann M; Rind D; Chapman R; Kumar V; Kahn S; Carlson J
    J Drugs Dermatol; 2018 Jul; 17(7):750-756. PubMed ID: 30005097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alopecia Universalis and Atopic Dermatitis Improvement with Dupilumab: Demonstration of a Shared Pathophysiology and Clinical Efficacy.
    Dobkin H; Mullen R; Zirwas M
    Skinmed; 2019; 17(2):139-140. PubMed ID: 31145072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.